Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 20887365)

1.

A randomized, double-blind, placebo-controlled, parallel-group study of rufinamide as adjunctive therapy for refractory partial-onset seizures.

Biton V, Krauss G, Vasquez-Santana B, Bibbiani F, Mann A, Perdomo C, Narurkar M.

Epilepsia. 2011 Feb;52(2):234-42. doi: 10.1111/j.1528-1167.2010.02729.x. Epub 2010 Sep 30.

PMID:
20887365
2.

A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizures.

Elger CE, Stefan H, Mann A, Narurkar M, Sun Y, Perdomo C.

Epilepsy Res. 2010 Feb;88(2-3):255-63. doi: 10.1016/j.eplepsyres.2009.12.003. Epub 2010 Jan 12.

PMID:
20061123
3.

Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial.

Brodie MJ, Rosenfeld WE, Vazquez B, Sachdeo R, Perdomo C, Mann A, Arroyo S.

Epilepsia. 2009 Aug;50(8):1899-909. doi: 10.1111/j.1528-1167.2009.02160.x. Epub 2009 Jun 1.

PMID:
19490053
4.

Rufinamide: a new antiepileptic medication for the treatment of seizures associated with lennox-gastaut syndrome.

Wisniewski CS.

Ann Pharmacother. 2010 Apr;44(4):658-67. doi: 10.1345/aph.1M679. Epub 2010 Mar 16. Review.

PMID:
20233912
5.

Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study.

Elger C, Halász P, Maia J, Almeida L, Soares-da-Silva P; BIA-2093-301 Investigators Study Group.

Epilepsia. 2009 Mar;50(3):454-63. doi: 10.1111/j.1528-1167.2008.01946.x. Epub 2009 Feb 21.

PMID:
19243424
6.

Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.

Brodie MJ, Duncan R, Vespignani H, Solyom A, Bitenskyy V, Lucas C.

Epilepsia. 2005 Jan;46(1):31-41.

PMID:
15660766
7.
8.

Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience.

Kluger G, Kurlemann G, Haberlandt E, Ernst JP, Runge U, Schneider F, Makowski C, Boor R, Bast T.

Epilepsy Behav. 2009 Mar;14(3):491-5. doi: 10.1016/j.yebeh.2008.12.013. Epub 2009 Jan 20.

PMID:
19162229
9.

Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.

Halász P, Kälviäinen R, Mazurkiewicz-Beldzińska M, Rosenow F, Doty P, Hebert D, Sullivan T; SP755 Study Group.

Epilepsia. 2009 Mar;50(3):443-53. doi: 10.1111/j.1528-1167.2008.01951.x. Epub 2009 Jan 17.

PMID:
19183227
10.

Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo-controlled trials.

Sperling MR, Greenspan A, Cramer JA, Kwan P, Kälviäinen R, Halford JJ, Schmitt J, Yuen E, Cook T, Haas M, Novak G.

Epilepsia. 2010 Mar;51(3):333-43. doi: 10.1111/j.1528-1167.2009.02318.x. Epub 2009 Oct 27.

PMID:
19863578
11.

Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.

Wu XY, Hong Z, Wu X, Wu LW, Wang XF, Zhou D, Zhao ZX, Lv CZ.

Epilepsia. 2009 Mar;50(3):398-405. doi: 10.1111/j.1528-1167.2008.01729.x. Epub 2008 Jul 24. Erratum in: Epilepsia. 2009 Apr;50(4):971.

PMID:
18657175
12.

Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial.

French JA, Baroldi P, Brittain ST, Johnson JK; PROSPER Investigators Study Group.

Acta Neurol Scand. 2014 Mar;129(3):143-53. doi: 10.1111/ane.12207. Epub 2013 Dec 21.

13.
14.

Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial.

Chung S, Sperling MR, Biton V, Krauss G, Hebert D, Rudd GD, Doty P; SP754 Study Group.

Epilepsia. 2010 Jun;51(6):958-67. doi: 10.1111/j.1528-1167.2009.02496.x. Epub 2010 Jan 27.

PMID:
20132285
15.

Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures.

Faught E, Holmes GL, Rosenfeld WE, Novak G, Neto W, Greenspan A, Schmitt J, Yuen E, Reines S, Haas M.

Neurology. 2008 Nov 11;71(20):1586-93. doi: 10.1212/01.wnl.0000334751.89859.7f.

PMID:
19001248
16.

Tiagabine: efficacy and safety in adjunctive treatment of partial seizures.

Crawford P, Meinardi H, Brown S, Rentmeester TW, Pedersen B, Pedersen PC, Lassen LC.

Epilepsia. 2001 Apr;42(4):531-8.

PMID:
11440349
17.

Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.

Piña-Garza JE, Nordli DR Jr, Rating D, Yang H, Schiemann-Delgado J, Duncan B; Levetiracetam N01009 Study Group.

Epilepsia. 2009 May;50(5):1141-9. doi: 10.1111/j.1528-1167.2008.01981.x. Epub 2009 Feb 21.

PMID:
19243423
18.

Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial.

Cereghino JJ, Biton V, Abou-Khalil B, Dreifuss F, Gauer LJ, Leppik I.

Neurology. 2000 Jul 25;55(2):236-42.

PMID:
10908898
19.

Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy.

Ben-Menachem E, Gabbai AA, Hufnagel A, Maia J, Almeida L, Soares-da-Silva P.

Epilepsy Res. 2010 May;89(2-3):278-85. doi: 10.1016/j.eplepsyres.2010.01.014. Epub 2010 Mar 17.

PMID:
20299189
20.

Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures.

Gil-Nagel A, Lopes-Lima J, Almeida L, Maia J, Soares-da-Silva P; BIA-2093-303 Investigators Study Group.

Acta Neurol Scand. 2009 Nov;120(5):281-7. doi: 10.1111/j.1600-0404.2009.01218.x.

PMID:
19832771
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk